Category: Gene Therapy
Global Gene Therapy
-
Cell & Gene Therapy Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By Route of Administration (Oral, Intravenous, Ocular, Transdermal, Others), By Method (In Vitro v/s Ex Vivo), By Region and Competition Global Cell & Gene Therapy Drug Delivery ... Read More
-
Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035
... the years, an increasing number of nucleic acid-based therapies have received regulatory approval, highlighting the therapeutic potential and growing popularity of this class of therapeutics. Consequently, this has created increased demand for vectors, which can ... Read More
-
Global Viral Vector Manufacturing Market - 2023-2030
... forecast period 2023-2030. The global viral vector manufacturing market has witnessed significant growth in recent years. The increasing focus on next-generation viral vectors is driving up demand for viral vector manufacturing market trends. The viral ... Read More
-
Cell and Gene Therapy Market
... Cell therapy is the introduction of new cells into a patient’s body to grow, replace, or repair damaged tissue in order to treat a disease. A variety of different types of cells can be used ... Read More
-
Global Gene Therapy Viral Vector and Plasmid DNA Supply, Demand and Key Producers, 2023-2029
... a market growth of % CAGR during the forecast period (2023-2029). Viral vector and plasmid DNA are tools to transfer genetic material into cells. Viral vectors are generally utilized as vectors for gene therapy. There ... Read More
-
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... is used in diagnosis and treatment of diseases such as cancer, inherited diseases, viral infections, and others. The therapeutic DNA is introduced in host with the help of a vector. Adeno associated virus based vector ... Read More
-
Global Gene Therapy Viral Vector and Plasmid DNA Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... DNA market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and ... Read More
-
Global Adeno-Associated Virus (AAV) Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... valued at USD 1684.4 million in 2022 and is forecast to a readjusted size of USD 2966.6 million by 2029 with a CAGR of 8.4% during review period. The influence of COVID-19 and the Russia-Ukraine ... Read More
-
Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029
... of 8.4% CAGR during the forecast period (2023-2029). This report studies the global Adeno-Associated Virus (AAV) Gene Therapy demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world ... Read More
-
Viral Clearance Market Forecasts to 2030 – Global Analysis By Method (Viral Removal, Viral Inactivation and Viral Detection Method), Application (Recombinant Proteins, Blood and Blood Products, Cellular and Gene Therapy Products, Vaccines and Other Applications), End User and By Geography
... End User and By Geography According to Stratistics MRC, the Global Viral Clearance Market is accounted for $764.64 million in 2023 and is expected to reach $1938.15 million by 2030 growing at a CAGR of ... Read More
-
Cell and Gene Therapy Bioassay Services Market, 2021-2030
... modalities has increased over the years. As a result, several cell and gene therapies have been developed and approved for the treatment of a wide range of disease indications. In fact, at the time of ... Read More
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030 Given ... Read More
-
Global Cell and Gene Therapy Cold Chain Logistics Market Growth (Status and Outlook) 2023-2029
... US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Cell and Gene Therapy Cold Chain Logistics is estimated to increase from US$ ... Read More
-
Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis : Focus on Therapy Type, Offering, Process, Technology, Application, and Region - Analysis and Forecast, 2023-2033
... QC Market Industry Overview The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is anticipated to reach $10.65 billion by 2033, witnessing a CAGR of 16.85% during ... Read More
-
Global Viral Vector Market Size study & Forecast, by Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), by Application (Cell & Gene Therapy, Vaccine, Biopharmaceutical & Pharmaceutical Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, CROs & CMOs) and Regional Analysis, 2023-2030
... Companies, Academics & Research Institutes, CROs & CMOs) and Regional Analysis, 2023-2030 Global Viral Vector Market is valued at approximately USD 3.10 billion in 2022 and is anticipated to grow with a healthy growth rate ... Read More
-
Global Gene Therapy Market - 2023-2030
... gene therapy market is expected to exhibit a CAGR of 19.4% during the forecast period 2023-2030. Gene therapy is a medical treatment or prevention method that corrects the underlying genetic issue. Instead of utilizing medications ... Read More
-
Viral Vector Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach a value of US$ 3,975 Million by 2028, exhibiting a growth rate (CAGR) of 24.9% during 2023-2028. A viral vector is a tool used by molecular biologists for delivering genetic materials into cells. It ... Read More
-
Global Cell and Gene Therapy Cold Chain Logistics Market Report and Forecast 2023-2031
... at USD 1.6 billion in 2022, driven by the increasing adoption of cell and gene therapies across the globe. The market size is anticipated to grow at a CAGR of 15.59% during the forecast period ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
... global viral vector and plasmid DNA manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast period of 2023 to ... Read More
-
Genome Editing Market Forecasts to 2028 – Global Analysis By Product & Service (Reagents & Consumables, Services, Software & Systems, Cell Lines and Other Product & Services), By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), Antisense, Restriction Enzymes and Other Technologies), By Application (Cell Line Editing, Genetic Engineering, Drug Discovery & Development, Diagnostic Applications, Microorganisms Genetic Engineering, Gene Therapy and Other Applications), By End User (Clinical Research Organizations, Academics & Government Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organization and Other End Users) and By Geography
... (CRISPR), Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), Antisense, Restriction Enzymes and Other Technologies), By Application (Cell Line Editing, Genetic Engineering, Drug Discovery & Development, Diagnostic Applications, Microorganisms Genetic Engineering, Gene Therapy and ... Read More
-
Viral Vector Production Market By Viral Vector Type (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors), By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The viral vector production market was valued for $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, exhibiting a CAGR of 18.8% from 2023 to ... Read More
-
Global Cell and Gene Therapy Supply Chain and Logistics Market Growth (Status and Outlook) 2023-2029
... 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Cell and Gene Therapy Supply Chain and Logistics is estimated to ... Read More
-
Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. The growing prevalence of inherited diseases and acquired disorders; increasing construction of hospitals, clinics, and nursing homes; and rising popularity of new ... Read More
-
Global Viral Inactivation Market Report and Forecast 2023-2031
... products across the globe. The market size is anticipated to grow at a CAGR of 11.5% during the forecast period of 2023-2031 to achieve a value of USD 1640 million by 2031. Introduction Viral inactivation ... Read More
-
Global Virus Filtration Market Report and Forecast 2023-2031
... diseases, including cancer, diabetes, and autoimmune disorders. The market is expected to grow at a CAGR of 12.3% during the forecast period of 2023-2031 to attain a value of USD 13 billion by 2031. Virus ... Read More
Research Assistance
